News | November 11, 2014

TIDI Products Acquires CFI, Maker of Cath Lab Radiation Protection Equipment

Acquisition enhances radiation protection offerings in the cath lab


November 11, 2014 — TIDI Products LLC has acquired CFI Medical Solutions (CFI) of Fenton, Mich., a diversified medical device manufacturer and engineering resource for hospitals, distributors and global original equipment manufacturers.

CFI has expertise in the design, engineering and manufacturing of radiation protection, infection prevention and patient positioning systems that help clinicians improve the effectiveness of their practices and healthcare systems. The company’s innovation process is collaborative, developing products by working side-by-side with clinicians and physicians.

“We’ve seen some of the value added innovations, such as C-Armor and Zero-Gravity that CFI has developed in partnership with its healthcare professional network” said Kevin McNamara, president and CEO of TIDI. “We look forward to adopting CFI’s culture of innovative thinking throughout our business to further enhance TIDI’s mission of supporting caregivers and preventing infections.”

C-Armor is an expandable and collapsible sterile pouch that adheres to the patient drape at or above the level of the sterile field line during surgical procedures. Zero-Gravity is a suspended radiation protection system that provides greater protection to clinicians during fluoroscopic procedures.

Headquartered in Neenah, Wis., TIDI plans to continue CFI’s engineering and manufacturing operations for its domestic and international customers. CFI employs approximately 300 people at its manufacturing locations in Fenton, Mich., and its Changshu Yushan Protection Products Co. Ltd. facility in Changshu, China.

For more information: www.tidiproducts.com, www.cfimedical.com


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now